Key Takeaways
- • Alphacution Research Conservatory, a research platform led by Director of Research Paul Rowady, attributes recent unprecedented levels of negative beta among US large-cap stocks to a specific case study on its platform.
- • The source article is a short publisher summary and author bio; it does not provide quantitative data, methodology, or the case study's findings in the text available.
- • The piece is positioned as a research thought-leadership item focused on how technology affects trading and asset management.
Summary
The article is authored or attributed to Paul Rowady, Director of Research for Alphacution. Rowady describes Alphacution as a research and strategic advisory platform focused on modeling and benchmarking the impacts of technology on global financial markets and on the businesses of trading and asset management. He is a 35-year veteran of proprietary, quantitative, and derivatives trading.
The available text does not include the specific beta measurements, time periods, or the mechanisms the case study identifies as driving negative beta. Readers seeking the underlying analysis would need to consult the full Alphacution case study directly.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.